CIK: 0001299434 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value: $43.51M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | R1 RCM INC | 1,000,000 | $10.95M | 25.2% | $13.62 | — | COM | 77634L105 |
| CVS | CVS HEALTH CORP | 98,797 | $9.207M | 21.2% | $53.73 | +60.0% | COM | 126650100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 82,500 | $8.538M | 19.6% | $82.57 | +13.7% | COM | 09061G101 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 62,530 | $7.973M | 18.3% | $122.10 | -7.6% | COM | 98956P102 |
| GOOG | ALPHABET INC | 46,000 | $4.082M | 9.4% | $107.32 | -11.7% | CAP STK CL C | 02079K107 |
| EHTH | EHEALTH INC | 75,000 | $363K | 0.8% | $41.35 | -91.0% | COM | 28238P109 |
| MSFT | MICROSOFT CORP | 1,486 | $356K | 0.8% | $221.40 | +5.7% | COM | 594918104 |
| GOOGL | ALPHABET INC | 3,753 | $331K | 0.8% | $109.70 | -14.0% | CAP STK CL A | 02079K305 |
| V | VISA INC | 1,354 | $281K | 0.6% | $180.72 | +9.0% | COM CL A | 92826C839 |
| META | META PLATFORMS INC | 2,262 | $272K | 0.6% | $202.49 | -42.4% | CL A | 30303M102 |
| MA | MASTERCARD INCORPORATED | 779 | $271K | 0.6% | $281.21 | +15.0% | CL A | 57636Q104 |
| — | VYNE THERAPEUTICS INC | 1,570,000 | $236K | 0.5% | $3.33 | — | COM | 92941V209 |
| AAPL | APPLE INC | 1,778 | $231K | 0.5% | $137.15 | +2.6% | COM | 037833100 |
| ACN | ACCENTURE PLC IRELAND | 784 | $209K | 0.5% | $219.52 | +20.3% | SHS CLASS A | G1151C101 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 674 | $208K | 0.5% | $285.24 | +4.1% | CL B NEW | 084670702 |